|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Jul 31, 2024 |
Title |
AS01-adjuvanted vaccine promotes functional and epigenetic modifications in monocytes |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing Expression profiling by high throughput sequencing Other
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Oct 06, 2023 |
Last update date |
Jul 31, 2024 |
Contact name |
Viviane Jeanne Bechtold |
E-mail(s) |
viviane.x.bechtold@gsk.com
|
Organization name |
GSK
|
Department |
Molecular Biology
|
Lab |
Vaccinomics
|
Street address |
rue de l'Institut 89
|
City |
Rixensart |
State/province |
Brabant Wallon |
ZIP/Postal code |
1330 |
Country |
Belgium |
|
|
Platforms (2) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (107)
|
GSM7829741 |
CD3+ depleted, epigenetic: ATAC, D0, S3 |
GSM7829742 |
CD3+ depleted, epigenetic: ATAC, D180, S3 |
GSM7829743 |
CD3+ depleted, epigenetic: ATAC, D32, S3 |
GSM7829744 |
CD3+ depleted, epigenetic: ATAC, D44, S3 |
GSM7829745 |
CD3+ depleted, epigenetic: ATAC, D0, S7 |
GSM7829746 |
CD3+ depleted, epigenetic: ATAC, D180, S7 |
GSM7829747 |
CD3+ depleted, epigenetic: ATAC, D32, S7 |
GSM7829748 |
CD3+ depleted, epigenetic: ATAC, D44, S7 |
GSM7829749 |
CD3+ depleted, epigenetic: ATAC, D0, S8 |
GSM7829750 |
CD3+ depleted, epigenetic: ATAC, D180, S8 |
GSM7829751 |
CD3+ depleted, epigenetic: ATAC, D32, S8 |
GSM7829752 |
CD3+ depleted, epigenetic: ATAC, D44, S8 |
GSM7829753 |
CD3+ depleted, epigenetic: ATAC, D60, S8 |
GSM7829754 |
CD3+ depleted, epigenetic: ATAC, D0, S9 |
GSM7829755 |
CD3+ depleted, epigenetic: ATAC, D180, S9 |
GSM7829756 |
CD3+ depleted, epigenetic: ATAC, D32, S9 |
GSM7829757 |
CD3+ depleted, epigenetic: ATAC, D44, S9 |
GSM7829758 |
CD3+ depleted, epigenetic: ATAC, D0, S12 |
GSM7829759 |
CD3+ depleted, epigenetic: ATAC, D180, S12 |
GSM7829760 |
CD3+ depleted, epigenetic: ATAC, D32, S12 |
GSM7829761 |
CD3+ depleted, epigenetic: ATAC, D44, S12 |
GSM7829762 |
CD3+ depleted, epigenetic: ATAC, D60, S12 |
GSM7829763 |
CD3+ depleted, epigenetic: ATAC, D0, S14 |
GSM7829764 |
CD3+ depleted, epigenetic: ATAC, D180, S14 |
GSM7829765 |
CD3+ depleted, epigenetic: ATAC, D32, S14 |
GSM7829766 |
CD3+ depleted, epigenetic: ATAC, D44, S14 |
GSM7829767 |
CD3+ depleted, epigenetic: ATAC, D60, S14 |
GSM7829768 |
CD3+ depleted, epigenetic: ATAC, D0, S19 |
GSM7829769 |
CD3+ depleted, epigenetic: ATAC, D180, S19 |
GSM7829770 |
CD3+ depleted, epigenetic: ATAC, D32, S19 |
GSM7829771 |
CD3+ depleted, epigenetic: ATAC, D44, S19 |
GSM7829772 |
CD3+ depleted, epigenetic: GEX, D0, S3 |
GSM7829773 |
CD3+ depleted, epigenetic: GEX, D180, S3 |
GSM7829774 |
CD3+ depleted, epigenetic: GEX, D32, S3 |
GSM7829775 |
CD3+ depleted, epigenetic: GEX, D44, S3 |
GSM7829776 |
CD3+ depleted, epigenetic: GEX, D0, S7 |
GSM7829777 |
CD3+ depleted, epigenetic: GEX, D180, S7 |
GSM7829778 |
CD3+ depleted, epigenetic: GEX, D32, S7 |
GSM7829779 |
CD3+ depleted, epigenetic: GEX, D44, S7 |
GSM7829780 |
CD3+ depleted, epigenetic: GEX, D0, S8 |
GSM7829781 |
CD3+ depleted, epigenetic: GEX, D180, S8 |
GSM7829782 |
CD3+ depleted, epigenetic: GEX, D32, S8 |
GSM7829783 |
CD3+ depleted, epigenetic: GEX, D44, S8 |
GSM7829784 |
CD3+ depleted, epigenetic: GEX, D60, S8 |
GSM7829785 |
CD3+ depleted, epigenetic: GEX, D0, S9 |
GSM7829786 |
CD3+ depleted, epigenetic: GEX, D180, S9 |
GSM7829787 |
CD3+ depleted, epigenetic: GEX, D32, S9 |
GSM7829788 |
CD3+ depleted, epigenetic: GEX, D44, S9 |
GSM7829789 |
CD3+ depleted, epigenetic: GEX, D0, S12 |
GSM7829790 |
CD3+ depleted, epigenetic: GEX, D180, S12 |
GSM7829791 |
CD3+ depleted, epigenetic: GEX, D32, S12 |
GSM7829792 |
CD3+ depleted, epigenetic: GEX, D44, S12 |
GSM7829793 |
CD3+ depleted, epigenetic: GEX, D60, S12 |
GSM7829794 |
CD3+ depleted, epigenetic: GEX, D0, S14 |
GSM7829795 |
CD3+ depleted, epigenetic: GEX, D180, S14 |
GSM7829796 |
CD3+ depleted, epigenetic: GEX, D32, S14 |
GSM7829797 |
CD3+ depleted, epigenetic: GEX, D44, S14 |
GSM7829798 |
CD3+ depleted, epigenetic: GEX, D60, S14 |
GSM7829799 |
CD3+ depleted, epigenetic: GEX, D0, S19 |
GSM7829800 |
CD3+ depleted, epigenetic: GEX, D180, S19 |
GSM7829801 |
CD3+ depleted, epigenetic: GEX, D32, S19 |
GSM7829802 |
CD3+ depleted, epigenetic: GEX, D44, S19 |
GSM7829803 |
CD14+ isolated monocytes, GEX, D0, S3 |
GSM7829804 |
CD14+ isolated monocytes, GEX, D2, S3 |
GSM7829805 |
CD14+ isolated monocytes, GEX, D30, S3 |
GSM7829806 |
CD14+ isolated monocytes, GEX, D32, S3 |
GSM7829807 |
CD14+ isolated monocytes, GEX, D60, S3 |
GSM7829808 |
CD14+ isolated monocytes, GEX, D0, S6 |
GSM7829809 |
CD14+ isolated monocytes, GEX, D2, S6 |
GSM7829810 |
CD14+ isolated monocytes, GEX, D30, S6 |
GSM7829811 |
CD14+ isolated monocytes, GEX, D32, S6 |
GSM7829812 |
CD14+ isolated monocytes, GEX, D60, S6 |
GSM7829813 |
CD14+ isolated monocytes, GEX, D0, S7 |
GSM7829814 |
CD14+ isolated monocytes, GEX, D2, S7 |
GSM7829815 |
CD14+ isolated monocytes, GEX, D30, S7 |
GSM7829816 |
CD14+ isolated monocytes, GEX, D32, S7 |
GSM7829817 |
CD14+ isolated monocytes, GEX, D60, S7 |
GSM7829818 |
CD14+ isolated monocytes, GEX, D0, S8 |
GSM7829819 |
CD14+ isolated monocytes, GEX, D2, S8 |
GSM7829820 |
CD14+ isolated monocytes, GEX, D30, S8 |
GSM7829821 |
CD14+ isolated monocytes, GEX, D32, S8 |
GSM7829822 |
CD14+ isolated monocytes, GEX, D60, S8 |
GSM7829823 |
CD14+ isolated monocytes, GEX, D0, S9 |
GSM7829824 |
CD14+ isolated monocytes, GEX, D2, S9 |
GSM7829825 |
CD14+ isolated monocytes, GEX, D30, S9 |
GSM7829826 |
CD14+ isolated monocytes, GEX, D32, S9 |
GSM7829827 |
CD14+ isolated monocytes, GEX, D60, S9 |
GSM7829828 |
CD14+ isolated monocytes, GEX, D0, S10 |
GSM7829829 |
CD14+ isolated monocytes, GEX, D2, S10 |
GSM7829830 |
CD14+ isolated monocytes, GEX, D30, S10 |
GSM7829831 |
CD14+ isolated monocytes, GEX, D32, S10 |
GSM7829832 |
CD14+ isolated monocytes, GEX, D60, S10 |
GSM7829833 |
CD14+ isolated monocytes, GEX, D0, S12 |
GSM7829834 |
CD14+ isolated monocytes, GEX, D2, S12 |
GSM7829835 |
CD14+ isolated monocytes, GEX, D30, S12 |
GSM7829836 |
CD14+ isolated monocytes, GEX, D32, S12 |
GSM7829837 |
CD14+ isolated monocytes, GEX, D60, S12 |
GSM7829838 |
CD14+ isolated monocytes, GEX, D0, S14 |
GSM7829839 |
CD14+ isolated monocytes, GEX, D2, S14 |
GSM7829840 |
CD14+ isolated monocytes, GEX, D30, S14 |
GSM7829841 |
CD14+ isolated monocytes, GEX, D32, S14 |
GSM7829842 |
CD14+ isolated monocytes, GEX, D60, S14 |
GSM7829843 |
CD14+ isolated monocytes, GEX, D0, S19 |
GSM7829844 |
CD14+ isolated monocytes, GEX, D2, S19 |
GSM7829845 |
CD14+ isolated monocytes, GEX, D30, S19 |
GSM7829846 |
CD14+ isolated monocytes, GEX, D32, S19 |
GSM7829847 |
CD14+ isolated monocytes, GEX, D60, S19 |
|
This SuperSeries is composed of the following SubSeries:
|
GSE244792 |
AS01-adjuvanted vaccine promotes functional and epigenetic modifications in monocytes [scATAC-seq] |
GSE244793 |
AS01-adjuvanted vaccine promotes functional and epigenetic modifications in monocytes [scRNA-seq] |
GSE244794 |
AS01-adjuvanted vaccine promotes functional and epigenetic modifications in monocytes [RNA-seq] |
GSE244799 |
AS01-adjuvanted vaccine promotes functional and epigenetic modifications in monocytes [Nanostring panel] |
|
Relations |
BioProject |
PRJNA1024908 |
Supplementary file |
Size |
Download |
File type/resource |
GSE244795_RAW.tar |
2.5 Gb |
(http)(custom) |
TAR (of H5) |
|
|
|
|
|